Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Heart, Lung & Circulation|March 8, 2016
Clinical Challenges in Catecholaminergic Polymorphic Ventricular TachycardiaJacopo F Imberti, Katherine Underwood, Andrea Mazzanti, et al.Current Heart Failure Reports|February 17, 2022
Telemedical Monitoring Based on Implantable Devices-the Evolution Beyond the CardioMEMS™ TechnologyAgnieszka Kotalczyk, Jacopo F Imberti, Gregory Y H Lip, et al.International Journal of Stroke : Official Journal of the International Stroke Society|September 23, 2021
Oral anticoagulation improves survival in very elderly Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registryYutao Guo, Agnieszka Kotalczyk, Jacopo F Imberti, et al.European Heart Journal. Quality of Care & Clinical Outcomes|August 14, 2021
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registryYutao Guo, Agnieszka Kotalczyk, Jacopo F Imberti, et al.European Heart Journal. Quality of Care & Clinical Outcomes|August 9, 2021
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registryYutao Guo, Agnieszka Kotalczyk, Jacopo F Imberti, et al.European Journal of Clinical Investigation|January 26, 2022
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patientsYutao Guo, Jacopo F Imberti, Agnieszka Kotalczyk, et al.Kardiologia Polska|October 6, 2020
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenarioGiuseppe Boriani, Niccolò Bonini, Alessandro Albini, et al.JACC. Asia|November 7, 2022
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial FibrillationYutao Guo, Jacopo F Imberti, Agnieszka Kotalczyk, et al.Current Pharmaceutical Design|February 12, 2021
Red Cell Distribution Width: A Routinely Available Biomarker with Important Clinical Implications in Patients with Atrial FibrillationAnna C Valenti, Marco Vitolo, Jacopo F Imberti, et al.European Journal of Internal Medicine|May 11, 2023
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022Giuseppe Boriani, Andrea Venturelli, Jacopo F Imberti, et al.Pageof 5